[Hiring] Senior Director, US Medical Affairs Strategy Lead @Revolution Medicines

Role Description

As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

Reporting to the VP US Medical Affairs Strategy Lead, the Senior Director, US Medical Affairs, will be responsible for developing and executing the US Medical Affairs (USMA) strategy and tactical plans with a focus on launch readiness and life cycle management for an individual asset in gastrointestinal (GI) and emerging indications.

Qualifications

• An advanced doctorate degree (PharmD, PhD, MD, DO or equivalent) in medical/scientific area is required.
• 15+ years of relevant experience in biotech or pharmaceutical industry focused on Medical Affairs, with cross-functional headquarter experience and on field-based teams or equivalent clinical and or academic/research experience.
• Must have a strong scientific background in GI cancer with a good understanding of biomarker-driven disease and ability to effectively analyze, synthesize, and communicate complex scientific information.
• Direct, hands-on experience executing the activities of various functions within medical affairs (training, medical communications, medical information, expanded access programs, evidence generation, publications).
• Proven track record of clinical trial support including protocol development/review, site selection support, enrollment support, and data analysis.
• Excellent interpersonal, written, and presentation skills with the ability to effectively communicate complex scientific data with a strong point of view to diverse audiences.
• Thrives in fast-paced, dynamic environment and ability to multi-task independently with limited supervision.
• Strong networking skills with deep existing relationships with GI cancer healthcare professionals including US top key opinion leaders required.

Requirements

• Develops and executes the USMA strategy and medical objectives including activities related to scientific engagement and communication, evidence generation, internal education, and patient advocacy.
• Develops and executes a Health Care Professional (HCP) engagement strategy to gather insights to inform the medical strategy.
• Acts as the US medical representative on cross-functional teams.
• Serves as a therapeutic area content expert.
• Participates in the Global Medical Affairs Team (GMAT) and US Medical Affairs Team (USMAT) to execute medical strategies, contribute to the operations and oversight of medical activities, and work cross-functionally to support associated pre-launch activities.
• Supports the execution of routine gap assessments leading to the development/refinement of a publication strategy, an evidence generation plan, and tactical plan as part of the overall USMA plan.
• Provides medical leadership in scientific engagement activities with key external stakeholders through organizing and leading advisory boards, studies investigator interactions, congress activities, and peer-to-peer discussions with the goal of communicating scientific insights to internal teams to drive strategy.
• Communicates clinical and scientific data to KOLs and other healthcare professionals through presentations, educational programs, and scientific discussions.
• Represents various medical affairs functions in cross-functional strategy team meetings including Clinical and Safety sub-teams, Global Brand Team, Global Product Team, Patient Advocacy, Market Access, and other cross-functional strategic discussions.
• Works closely with the Clinical and US MSL teams to provide enrollment, scientific, and engagement support to ensure clinical trials meet study timelines.
• Partners with RWE strategy and Biomarker/CDx teams on related integrated evidence generation strategies and activities as part of the USMA Plan.
• Works with the Patient Advocacy and Grants teams to incorporate the patient voice and define external medical education strategies for independent grants, respectively.
• Provides medical support for medical congresses and collaborates across US and Global functions to develop, review, and align on key scientific communication points and medical information response documents within legal and compliance guidelines.
• Supports the review and approval of abstracts, manuscripts, corporate communications, and other data disclosure documents as well as internal stakeholder medical education activities related to the compound data and related competitor data.
• Collaborates with stakeholders across the organization, including, but not limited to, Clinical Development and Operations, Commercial Operations, Program Management, Business Development, Regulatory, Safety, and Compliance teams.

Benefits

• Base pay salary range for this full-time position is $232,000 — $290,000 USD.
• Competitive cash compensation.
• Robust equity awards.
• Strong benefits.
• Significant learning and development opportunities.

Company Description

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.

The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.

The company’s RAS(ON) inhibitors currently in clinical development include:

• daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;
• elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor;
• zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor;
• RMC-5127, a RAS(ON) G12V-selective inhibitor.